Sleep and diabetes‐specific psycho‐behavioral outcomes of a new automated insulin delivery system in young children with type 1 diabetes and their parents
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Data on the use of Control-IQ, the latest FDA-approved automated insulin delivery (AID) system for people with T1D 6 years of age or older is still scarce, particularly regarding nonglycemic outcomes. Children with T1D and their parents are at higher risk for sleep disturbances. This study assesses sleep, psycho-behavioral and glycemic outcomes of AID compared to sensor-augmented pump therapy (SAP) therapy in young children with T1D and their parents. METHODS: Thirteen parents and their young children (ages 7-10) on insulin pump therapy were enrolled. Children completed an initial 4-week study with SAP using their own pump and a study CGM followed by a 4-week phase of AID. Sleep outcomes for parents and children were evaluated through actigraphy watches. Several questionnaires were administered at baseline and at the end of each study phase. CGM data were used to assess glycemic outcomes. RESULTS: Actigraphy data did not show any significant change from SAP to AID, except a reduction of number of parental awakenings during the night (p = 0.036). Parents reported statistically significant improvements in Pittsburgh Sleep Quality Index total score (p = 0.009), Hypoglycemia Fear Survey total score (p = 0.011), diabetes-related distress (p = 0.032), and depression (p = 0.023). While on AID, time in range (70-180 mg/dL) significantly increased compared to SAP (p < 0.001), accompanied by a reduction in hyperglycemia (p = 0.001). CONCLUSIONS: These results suggest that use of AID has a positive impact on glycemic outcomes in young children as well as sleep and diabetes-specific quality of life outcomes in their parents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237 · cited 3×
“The glycemic outcomes for each condition are presented in Table 1 and are computed from CGM data as recommended by the recent international consensus on use of CGM.(30,31) The time in range (TIR) of 70–180 mg/dL improved significantly from SAP to AID (mean 50.”
MethodInfluentialNational Sleep Foundation’s updated sleep duration recommendations: final report
Hirshkowitz, M., Whiton, K., Albert, S. M., Alessi, C., Bruni, O., DonCarlos, L., Hazen, N., Herman, J., Adams Hillard, P. J., Katz, E. S., et al. (2015) · Sleep Health · doi:10.1016/j.sleh.2015.10.004 · Cited by 2,348
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069 · cited 3×
“The glycemic outcomes for each condition are presented in Table 1 and are computed from CGM data as recommended by the recent international consensus on use of CGM.(30,31) The time in range (TIR) of 70–180 mg/dL improved significantly from SAP to AID (mean 50.”
MethodInfluentialNational Sleep Foundation's sleep quality recommendations: first report
Ohayon, M., Wickwire, E. M., Hirshkowitz, M., Albert, S. M., Avidan, A., Daly, F. J., Dauvilliers, Y., Ferri, R., Fung, C., Gozal, D., et al. (2017) · Sleep Health · doi:10.1016/j.sleh.2016.11.006 · Cited by 1,304
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Brown, S. A., Kovatchev, B. P., Raghinaru, D., Lum, J. W., Buckingham, B. A., Kudva, Y. C., Laffel, L. M., Levy, C. J., Pinsker, J. E., Wadwa, R. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1907863 · Cited by 1,030 · cited 1×
“Although this study is limited due to one-month duration of use and sequential use of SAP and AID, we have previously reported that glycemic improvements with this system can be seen after 1 month of use.(2) Moreover, parents in this study experienced a wide range of improvements in subjective outcomes, ranging from r…”
BackgroundSelf-citationSafety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes
Bergenstal, R. M., Garg, S., Weinzimer, S. A., Buckingham, B. A., Bode, B. W., Tamborlane, W. V., & Kaufman, F. R. (2016) · JAMA · doi:10.1001/jama.2016.11708 · Cited by 644
Psychometric properties of the hypoglycemia fear survey-ii for adults with type 1 diabetes
Gonder-Frederick, L. A., Schmidt, K. M., Vajda, K. A., Greear, M. L., Singh, H., Shepard, J. A., & Cox, D. J. (2011) · Diabetes Care · doi:10.2337/dc10-1343 · Cited by 337
Self-citationBenhamou, P.-Y., Franc, S., Reznik, Y., Thivolet, C., Schaepelynck, P., Renard, E., Guerci, B., Chaillous, L., Lukas-Croisier, C., Jeandidier, N., et al. (2019) · The Lancet Digital Health · doi:10.1016/s2589-7500(19)30003-2 · Cited by 217
Partial sleep restriction decreases insulin sensitivity in type 1 diabetes
Donga, E., van Dijk, M., van Dijk, J. G., Biermasz, N. R., Lammers, G.-J., van Kralingen, K., Hoogma, R. P. L. M., Corssmit, E. P. M., & Romijn, J. A. (2010) · Diabetes Care · doi:10.2337/dc09-2317 · Cited by 165 · cited 1×
“Previous studies have suggested that extreme levels of both hyper- and hypoglycemic events may disrupt sleep, and inversely, sleep disruptions and subsequent sleep deprivation may be associated with decreased melatonin production and increased insulin resistance, potentially through increased cortisol secretion..(8-13…”
BackgroundPsychometric properties of the parent and child problem areas in diabetes measures
Evans, M. A., Weil, L. E. G., Shapiro, J. B., Anderson, L. M., Vesco, A. T., Rychlik, K., Hilliard, M. E., Antisdel, J., & Weissberg-Benchell, J. (2019) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsz018 · Cited by 75
Brod, M., Pohlman, B., Wolden, M., & Christensen, T. (2013) · Quality of Life Research · doi:10.1007/s11136-012-0234-3 · Cited by 71
Randomized Controlled Trial of Mobile Closed-Loop Control
Kovatchev, B., Anderson, S. M., Raghinaru, D., Kudva, Y. C., Laffel, L. M., Levy, C., Pinsker, J. E., Wadwa, R. P., Buckingham, B., Doyle, F. J., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1310 · Cited by 60
Self-citationPsychosocial impact of the bionic pancreas during summer camp
Weissberg-Benchell, J., Hessler, D., Polonsky, W. H., & Fisher, L. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816640289 · Cited by 47 · cited 1×
“This 37 item questionnaire, rated on a 5 point Likert scale, has been used in previous AID research (bionic pancreas) and was adapted for this study.(27) It yields to two subscales scores (Burdens and Benefits) with higher scores in each subscale”
Method
Cited by
Phillip, M., Nimri, R., Bergenstal, R. M., Barnard-Kelly, K., Danne, T., Hovorka, R., Kovatchev, B. P., Messer, L. H., Parkin, C. G., Ambler-Osborn, L., et al. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac022 · Cited by 443
Self-citationA Systematic Review of Commercial Hybrid Closed-Loop Automated Insulin Delivery Systems
Peacock, S., Frizelle, I., & Hussain, S. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01394-5 · Cited by 122
Fear of hypoglycemia and sleep in children with type 1 diabetes and their parents
Schierloh, U., Aguayo, G. A., Fichelle, M., De Melo Dias, C., Schritz, A., Vaillant, M., Barnard-Kelly, K., Cohen, O., Gies, I., & de Beaufort, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1419502 · Cited by 7
Metadata
- Authors
- Bisio, A., Brown, S. A., McFadden, R., Pajewski, M., Yu, P. L., DeBoer, M., Schoelwer, M. J., Bonner, H. G., Wakeman, C. A., Cherñavvsky, D. R., & Gonder‐Frederick, L.
- Venue
- Pediatric Diabetes
- Publisher
- Wiley
- Published
- 2020-12-08
- Volume
- 22
- Issue
- 3
- Pages
- 495-502
- ISSN
- 1399-543X (ISSN-L)
- 1399-5448
- OpenAlex
- W3110331541
- Cited by
- 57
- References
- 13
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.